
Schrodinger Inc (AKA: Schrödinger LLC) Profile last edited on: 2/19/2021
CAGE: 1CJB1
UEI: NSUESF38DS83
Business Identifier: Chemical simulation software: computational drug design Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
120 West 45th Street 17th Floor
New York, NY 10036
New York, NY 10036
(212) 295-5800 |
info@schrodinger.com |
www.schrodinger.com |
Location: Multiple
Congr. District: 12
County: New York
Congr. District: 12
County: New York
Public Profile
Based in Oregon with US faciliites in NY, CA, MD and MA; an overseas presence in Europe, Japan and India and having business partners in China and Korea, employing advanced computational methods that transform the way scientists design therapeutics and materials, Schrödinger, LLC develops chemical simulation software for use in pharmaceutical and biotechnology research. The company provides products ranging from general molecular modeling programs to a suite of drug design software, including ligand- and structure-based methods. Also offered are small-molecule drug discovery, biologics, materials science, and discovery informatics solutions; and PyMOL, a 3D molecular visualization solution. The companys software allows scientists to accelerate their research and development activities, as well as to make novel discoveries. It serves pharmaceutical and biotech companies, universities, non-profit institutions, and governmental agencies, including supercomputing centers.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
250-500Revenue Range
20M-50MVC funded?
YesPublic/Private
Publicly TradedStock Info
NASDAQ : SDGRIP Holdings
20-24Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2012 | 2 | NIH | $1,359,974 | |
Project Title: Commercial Software for Modeling of G Protein-Coupled Receptors | ||||
2003 | 1 | NIH | $99,987 | |
Project Title: Modeling Metal-Containing Biological Systems | ||||
2000 | 2 | NIH | $826,347 | |
Project Title: Polarizable Force Fields For Peptides And Proteins | ||||
1998 | 2 | NSF | $462,608 | |
Project Title: Software for Fast and Accurate Calculations on Transition-Metal Systems | ||||
1998 | 1 | NSF | $100,000 | |
Project Title: Accurate Thermochemistry for Large Systems |
Key People / Management
Ramy Farid -- President, Chief Executive Officer
Charles Ardai
Cony D'Cruz -- Senior Vice President, Business Development
Richard Friesner -- Founder
Wlliam Goddard -- Founder
Jean-Marc Langlois
Alessandro Monge -- Vice President, Strategic Business
Mark Murcko -- Senior Vice President, Strategy
Robert B Murphy
Murco Ringnalda -- Chief Financial Officer, Co-Founder
Charles Ardai
Cony D'Cruz -- Senior Vice President, Business Development
Richard Friesner -- Founder
Wlliam Goddard -- Founder
Jean-Marc Langlois
Alessandro Monge -- Vice President, Strategic Business
Mark Murcko -- Senior Vice President, Strategy
Robert B Murphy
Murco Ringnalda -- Chief Financial Officer, Co-Founder